Bio-Rad Laboratories, Inc. BIO.B Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s allowance for doubtful accounts receivable (current)?
- Bio-Rad Laboratories, Inc. (BIO.B) reported allowance for doubtful accounts receivable (current) of $4.9M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s allowance for doubtful accounts receivable (current) changed year-over-year?
- Bio-Rad Laboratories, Inc.'s allowance for doubtful accounts receivable (current) decreased by 37.2% year-over-year, from $7.8M to $4.9M.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s allowance for doubtful accounts receivable (current)?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories, Inc.'s allowance for doubtful accounts receivable (current) has grown at a -22.6% compound annual growth rate (CAGR), from $19.81M to $5.5M.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.